FAIM
INMB icon

Financial Advocates Investment Management’s INmune Bio INMB Stock Holding History

Financial Advocates Investment Management’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,500
Closed -$35.8K – 321
2025
Q2 		$35.8K Hold
15,500
– – ﹤0.01% 618
2025
Q1 		$121K Hold
15,500
– – 0.01% 697
2024
Q4 		$72.4K Buy
15,500
+2,000
+15% +$10.4K ﹤0.01% 732
2024
Q3 		$72.8K Buy
13,500
+2,000
+17% +$14.2K ﹤0.01% 747
2024
Q2 		$101K Buy
11,500
+1,000
+10% +$9.86K 0.01% 707
2024
Q1 		$123K Sell
10,500
-2,000
-16% -$24.2K 0.01% 732
2023
Q4 		$141K Buy
+12,500
New +$105K 0.01% 696
2023
Q2 		– Sell
-11,500
Closed -$92.4K – 738
2023
Q1 		$74.3K Sell
11,500
-2,151
-16% -$17.3K 0.01% 718
2022
Q4 		$86.5K Buy
+13,651
New +$96.9K 0.01% 725
2022
Q3 		– Sell
-15,167
Closed -$134K – 786
2022
Q2 		$134K Hold
15,167
– – 0.01% 646
2022
Q1 		$128K Hold
15,167
– – 0.01% 703
2021
Q4 		$155K Sell
15,167
-1,500
-9% -$22.2K 0.01% 742
2021
Q3 		$324K Sell
16,667
-3,000
-15% -$57.9K 0.02% 596
2021
Q2 		$345K Hold
19,667
– – 0.02% 572
2021
Q1 		$234K Buy
19,667
+1,500
+8% +$27K 0.02% 679
2020
Q4 		$313K Hold
18,167
– – 0.02% 552
2020
Q3 		$187K Sell
18,167
-217,794
-92% -$2.22M 0.02% 594
2020
Q2 		$1.24M Sell
235,961
-17,500
-7% -$88.1K 0.12% 212
2020
Q1 		$844K Buy
253,461
+28,794
+13% +$130K 0.12% 200
2019
Q4 		$1.3M Hold
224,667
– – 0.14% 173
2019
Q3 		$1.33M Buy
+224,667
New +$1.66M 0.15% 154

Other funds holding INMB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Advocates Investment Management's INMB Position: Q3 2025 in Review

Financial Advocates Investment Management sold out of INmune Bio (INMB) in Q3 2025, closing a stake of 15,500 shares — an estimated $35.8K sold.

Financial Advocates Investment Management first reported a position in INMB in Q3 2019 and held it in 21 quarters. The position peaked at $1.33M in Q3 2019. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • Financial Advocates Investment Management reported no remaining INmune Bio position as of Q3 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 15,500 INmune Bio shares in Q3 2025, an estimated $35.8K.
  • Financial Advocates Investment Management first reported a position in INmune Bio in Q3 2019 and held it in 21 quarters.
  • Financial Advocates Investment Management's INmune Bio position peaked at $1.33M in Q3 2019.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on Financial Advocates Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.